New Delhi: The National Pharmaceutical Pricing Authority has extended the validity of the existing ceiling prices for orthopaedic knee implants used in knee replacement systems by two months, until January 15, 2027.
As per a notification in the Press Gazette, the extension comes as the authority considers representations received from manufacturers and industry associations.
The existing price controls were last extended on November 14, 2025, and were due to remain in force until November 15, 2026.
The move comes amid growing demands for trade margin rationalisation for medical devices.
The Association of Indian Medical Device Industry (AiMed), Forum Director, Rajiv Nath said, “AiMeD welcomes and is highly appreciative of NPPA’s decision to extend the existing ceiling prices of knee implants while stakeholder representations are being examined. India now has strong indigenous manufacturing capabilities and advanced technologies are already available within the current pricing framework. Any future price cap revision decision should be based on objective assessment of market data, patient affordability and the need to strengthen domestic manufacturing under the Make in India and Atmanirbhar Bharat initiatives.”
